ADAPTIMMUNE THERAPEUTICS PLC Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of 0.5 GBP/shares as of 2024-12-31, per its 10-K filed 2025-03-24.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2025-03-24

2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price 0.65 GBP.
2018-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price 0.55 GBP.
2017-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price 0.51 GBP.
2016-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price 0.41 GBP.

GBP

Period end	Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
2020-12-31	0.65 GBP 10-K · filed 2021-02-25
2018-12-31	0.55 GBP 10-K · filed 2019-02-27
2017-12-31	0.51 GBP 10-K · filed 2018-03-15
2016-12-31	0.41 GBP 10-K · filed 2017-03-13

GBP/shares

Period end	Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
2024-12-31	0.50 GBP/shares 10-K · filed 2025-03-24
2023-12-31	0.57 GBP/shares 10-K · filed 2024-03-06
2022-12-31	0.64 GBP/shares 10-K · filed 2023-03-06
2021-12-31	0.66 GBP/shares 10-K · filed 2022-03-14
2020-12-31	0.65 GBP/shares 10-K · filed 2021-02-25
2018-12-31	0.55 GBP/shares 10-K · filed 2019-02-27
2017-12-31	0.51 GBP/shares 10-K · filed 2018-03-15
2016-12-31	0.41 GBP/shares 10-K · filed 2017-03-13